Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
ConclusionsAlthough the efficacy of PrEP with hydroxychloroquine for preventing COVID-19 could not be evaluated, our study showed that PrEP with hydroxychloroquine at low doses is safe.Trial registrationClinicalTrials.govNCT04331834. Registered on April 2, 2020.
Source: Trials - Category: Research Source Type: clinical trials
More News: Clinical Trials | COVID-19 | Epidemics | Epidemiology | Gastroenterology | Hydroxychloroquine | Research | SARS | Spain Health | Study